PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for January 2, 2005 Subscribe to this News Feed    
 

World Financial News Network Recommends AVVAA World Health Care Products

Dr. Joseph de Beauchamp of World Financial News Network started coverage and gives favorable analysis to AVVAA World Health Care Products works in the skincare health industry to help people cure skin irritations with natural products.

Seattle, Washington. (PRWEB) January 2, 2005 -- WFNN's consistently outperforms established industry benchmark indicators. Based on in-depth research and analysis, their analysts recommend securities worldwide showing the highest probability for stock price appreciation. With constant vigil, WFNN looks for economic opportunities in the private and public company sectors.

Dr. Joseph de Beauchamp, WFNN's Chief Independent Analyst, said, AvVaa World Health Care Products intends to continually enhance the website to include other complementary products as they become available and add dynamic features such as a "Find a Retailer" and "Find a Dermatologist" which will allow avVaa's partners another opportunity to reach new consumers and patients. Three of avVaa's natural and effective skin care products are highlighted: Neuroskin Spray, a non-toxic product specifically formulated to relieve the symptoms due to psoriasis, eczema, seborrheic dermatitis and other skin irritations. AVVAA shows a number of products to increase the revenues: DerMAC Spray, a steroid-free treatment for acne; and Itch Relief Spray, a double-action anti-itch spray for relief of itching caused by minor burns, insect bites, and other skin irritations. WFNN believes the company started to launch a better visibility campaign. With the market growing for this sector, Wfnn sees this company stock moving up to $2.00 per share, and starting to earn some profits per share."

For brief information of this new, dynamic company, examine: http://wfnn.info displaying in the search engine section.

About WFNN: World Financial News Network provides a unique blend of data, timely information and today's technologies to assist with up-to-the-minute investment and economic values on markets and investments around the world.

About AVVAA World Health Care Products: AVVAA World Health Care Products started as a US global biotech company. AVVAA provides effective, all natural, therapeutic skin care products that improve quality of life and well being for customers. AVVAA distributes FDA compliant and DIN approved core products, which provide effective all natural, nontoxic skin, care for difficult treatable diseases like eczema, psoriasis and acne. Over 10 years of European research trials has revealed a 75% success rate in product performance in the first four weeks. The Company's future line of products include skin care remedies for radiation burns in cancer patients and a variety of products for difficult to treat animal skin diseases. Their proven product line is ready to go to the market worldwide and AVVAA has pipelines in place and orders waiting to be fulfilled.

Jack Farley
jfarley@avvaa.com
AVVW -- AVVAA World Health Care Products, Inc.
P.O. Box 335
3018 Schaeffer Rd.
Falkland, BC V0E 1W0
Canada
http://www.avvaa.com
250-379-2727

# # #

Technorati Tags

Bookmark -  Del.icio.us | Furl It | Technorati | Ask | MyWeb | Propeller | Live Bookmarks | Newsvine | TailRank | Reddit | Slashdot | Digg | Stumbleupon | Google Bookmarks | Sphere | Blink It | Spurl


OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
Email this story to a colleague
CONTACT INFORMATION
Joseph De Beauchamp
WFNN
206-343-3912
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.